Targeting Treg signaling for the treatment of autoimmune diseases

A Spence, JE Klementowicz, JA Bluestone… - Current opinion in …, 2015 - Elsevier
A Spence, JE Klementowicz, JA Bluestone, Q Tang
Current opinion in immunology, 2015Elsevier
Highlights•Role of TCR, CD28, and IL2 in Treg identity and function.•Impact of PI3K-Akt-
mTOR signaling on Treg development, homeostasis, and function.•Importance of
epigenome in safeguarding Treg lineage stability after activation.•Rationalize design for
Treg targeted therapies for autoimmune diseases.Regulatory T (Treg) cells are crucial
players in the prevention of autoimmunity. Treg lineage commitment and functional stability
are influenced by selected extracellular signals from the local environment, shaped by …
Highlights
  • Role of TCR, CD28, and IL2 in Treg identity and function.
  • Impact of PI3K-Akt-mTOR signaling on Treg development, homeostasis, and function.
  • Importance of epigenome in safeguarding Treg lineage stability after activation.
  • Rationalize design for Treg targeted therapies for autoimmune diseases.
Regulatory T (Treg) cells are crucial players in the prevention of autoimmunity. Treg lineage commitment and functional stability are influenced by selected extracellular signals from the local environment, shaped by distinctive intracellular signaling network, and secured by their unique epigenetic profile. Recent advances in our understanding of the complex processes of Treg lineage differentiation, maintenance, and function has paved the way for developing strategies to manipulate these important cells for therapeutic benefit in many diseases. In this review, we will summarize recent advances in our understanding of Treg biology as well as Treg-targeted therapies in the context of autoimmune disease.
Elsevier